Delivery Order SPE2DB20D1004-SPE2DB22FF4P3
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,250.94 for the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 24, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $21,231.60 for the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through January 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $12,779.85 under a Firm Fixed Price contract with the Defense Logistics Agency (DLA). The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. This delivery order has a completion date of February 22, 2024. The contract was awarded on February 21, 2024, and there was no set-aside designation used. Amerisourcebergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $17,980.18 firm-fixed-price delivery order has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen is an experienced pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $11,498.77 delivery order contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has a completion date of February 27, 2024 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,043.92 for the pharmaceutical product COSENTYX 150 MG/ML SYRINGE. The award was made by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order with a Firm Fixed Price of $47,126.46 for the supply of Cosentyx 300 mg dose-2 pens. The award was made by the Defense Logistics Agency (DLA), a defense agency, on February 8, 2022, with a completion date of February 9, 2022. The contract does not have a set-aside designation, indicating it was competitively awarded. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of 4,563,637,340 units of COSENTYX SENSOREADY 150 MG PENML, a specialty pharmaceutical product. The $115,404.98 firm fixed-price delivery order has a completion date of February 13, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $2,409.22 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. The contract has an ultimate completion date of January 11, 2023 and was awarded on January 10, 2023. There is no set-aside designation indicated for this award. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $12,149.58 firm fixed-price delivery order is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty medication. The contract has an ultimate completion date of October 24, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF4P3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $5,972.52 for the pharmaceutical product COSENTYX 300 MG DOSE-2 PENSML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 4, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 4/1/22 |